Top compounds associated with response to GHR


Feature Type Standardized
Nominal ANOVA
mRNA AT-7519 GDSC1000 pan-cancer AAC -0.091 0.003
mRNA decitabine:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.095 0.004
mRNA Ispinesib Mesylate GDSC1000 pan-cancer AAC -0.097 0.004
mRNA leptomycin B CTRPv2 pan-cancer AAC -0.1 0.004
mRNA Docetaxel gCSI pan-cancer AAC -0.17 0.004
mRNA sitagliptin CTRPv2 pan-cancer AAC 0.2 0.005
mRNA Bleomycin GDSC1000 pan-cancer AAC -0.1 0.005
mRNA Vinblastine GDSC1000 pan-cancer AAC -0.1 0.005
mRNA dabrafenib CTRPv2 pan-cancer AAC 0.14 0.005
mRNA UNC0638:navitoclax (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.005
Download CSV